Novo Nordisk, Eli Lilly roll out obesity pills, prepare for Medicare coverage
Key Points:
- Novo Nordisk and Eli Lilly took their GLP-1 pill battle to the preeminent obesity meeting this weekend as they prepare for the next sea change in how patients receive their drugs.
- Novo Nordisk on Sund